An Asian life insurance company chose GroveStreet to create a healthcare impact portfolio in accordance with the United Nations’ Sustainable Development Goals
GroveStreet’s Solution:
- GroveStreet is actively building a portfolio of funds targeting biotech, medtech, digital health and healthcare services by leveraging our 20+ year relationships as an active HC investor, along with select emerging managers
- We worked directly with the client to understand their impact reporting preferences and developed proprietary capabilities to source and track key performance indicators to supplement their regular reporting
- Consistent with these objectives, GroveStreet is a signatory of the United Nations Principles for Responsible Investing (PRI) and coordinates with each of our investors to deliver custom solutions for their respective ESG goals